Form 4: Cardlytics Director Sells $452K in Stock

Cardlytics Director and 10% owner Clifford Sosin sold 400,000 shares of common stock over two days in August 2025.

Summary

• Clifford Sosin, a Director and 10% owner of Cardlytics, Inc. (CDLX), reported sales of common stock pursuant to a Rule 10b5-1 plan.
• On August 18, 2025, 200,000 shares were sold at an average price of $1.1411 per share.
• On August 19, 2025, an additional 200,000 shares were sold at an average price of $1.1227 per share.
• Following these transactions, Clifford Sosin's indirect beneficial ownership stands at 5,199,023 shares of Common Stock.
• The reporting person also indirectly holds $21,243,000 principal amount of the Issuer's 4.25% Convertible Senior Notes due April 1, 2029, which are convertible into 1,178,856 shares of Common Stock.
• The Issuer has the option, at its sole discretion, to settle conversions of the Notes in cash, shares of Common Stock, or a combination of cash and shares of Common Stock.

Sentiment

Score: 3

Explanation: The filing reports significant insider selling by a Director and 10% owner. While the sales were conducted under a Rule 10b5-1 plan, indicating they were pre-scheduled and not necessarily based on new material non-public information, the sheer volume of shares sold (400,000) can still be perceived negatively by the market as it reduces the insider's direct equity alignment.

Negatives

• A Director and 10% owner sold a significant number of shares (400,000 shares) over two consecutive days.
• The sales occurred at relatively low prices ($1.1411 and $1.1227 per share).
• While conducted under a Rule 10b5-1 plan, the reduction in direct equity ownership by a key insider can still be viewed with caution by the market.

Risks

• Potential negative market perception due to significant insider selling, even if pre-scheduled, which could lead to downward pressure on the stock price.
• Reduced alignment of interests between the insider and common shareholders as the insider's direct equity stake decreases.
• The issuer's option to settle convertible notes in cash, shares, or a combination introduces uncertainty regarding potential future dilution from the notes.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: May interpret the insider selling as a negative signal, potentially leading to decreased investor confidence and downward pressure on the stock price.

Key Dates

Recommendation

While the significant insider selling by a Director and 10% owner is a negative signal, the fact that the transactions were made pursuant to a Rule 10b5-1 plan mitigates the immediate negative interpretation, as these sales were pre-scheduled and not necessarily indicative of a new, immediate lack of confidence. However, the reduction in direct equity ownership by a key insider warrants caution. Investors should hold and monitor future filings and company performance for clearer directional signals.

Keywords

Cardlytics, CDLX, Clifford Sosin, Form 4, insider selling, stock sale, beneficial ownership, convertible notes, director, 10% owner